1207989-09-0
1207989-09-0
Chemical Structure
LGD-6972
- CAS. Nr.: 1207989-09-0
- Formula:C43H46N2O5S
- Molecular Weight:702.90
IUPAC Name: (R)-2-(4-(2-(4'-(tert-butyl)-[1,1'-biphenyl]-4-yl)-3-oxo-3-((2',4',6'-trimethyl-[1,1'-biphenyl]-4-yl)amino)propyl)benzamido)ethane-1-sulfonic acid
InChIKey: HKJMCBYPVCGZFB-LDLOPFEMSA-N
SMILES: O=C(NCCS(=O)(O)=O)C1=CC=C(C[C@H](C2=CC=C(C3=CC=C(C(C)(C)C)C=C3)C=C2)C(NC4=CC=C(C5=C(C)C=C(C)C=C5C)C=C4)=O)C=C1
Biological Activity: LGD-6972 is a selective and orally active glucagon receptor antagonist. LGD-6972 has the potential for type 2 diabetes research[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
LGD-6972 | 98.0% | LGD-6972 is a selective and orally active glucagon receptor antagonist. LGD-6972 has the potential for type 2 diabetes research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
